Last Name

John T. Lettieri

InstitutionMedical University of South Carolina
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stass H, Lettieri J, Vanevski KM, Willmann S, James LP, Sullivan JE, Arrieta AC, Bradley JS. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study. J Clin Pharmacol. 2019 May; 59(5):654-667. PMID: 30681729.
      View in: PubMed
    2. Gerisch M, Hafner FT, Lang D, Radtke M, Diefenbach K, Cleton A, Lettieri J. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects. Cancer Chemother Pharmacol. 2018 01; 81(1):195-206. PMID: 29188322.
      View in: PubMed
    3. Huang F, Ajavon A, Huang E, Lettieri J, Liu R, Peña C, Berse M. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects. Thyroid. 2017 09; 27(9):1118-1127. PMID: 28741453.
      View in: PubMed
    4. Lettieri JT, Scheerans C, Blunck M, Mazzu AL, Frey R, Mück W, Sundaresan PR. Assessment of the effects of renal impairment on the pharmacokinetics of the soluble guanylate cyclase activator cinaciguat after a single intravenous dose. J Clin Pharmacol. 2012 Aug; 52(8):1240-7. PMID: 21868716.
      View in: PubMed
    5. Lathia C, Lettieri J, Cihon F, Gallentine M, Radtke M, Sundaresan P. Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics. Cancer Chemother Pharmacol. 2006 May; 57(5):685-92. PMID: 16133532.
      View in: PubMed
    6. Goldman MP, Roberts TL, Skover G, Lettieri JT, Fitzpatrick RE. Optimizing wound healing in the face after laser abrasion. J Am Acad Dermatol. 2002 Mar; 46(3):399-407. PMID: 11862176.
      View in: PubMed
    7. Shah A, Krol G, Sundaresan P, Lettieri J, Falk R, Lasseter K, Heller AH. Pharmacokinetics of Nisoldipine Coat--Core Formulation in Subjects with Liver Cirrhosis. Am J Ther. 1995 Jan; 2(1):15-19. PMID: 11850642.
      View in: PubMed
    Lettieri's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description